Schedule of Outstanding Warrants (Details) - Warrant [Member] - $ / shares |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Class of Warrant or Right [Line Items] | |||
| Number of warrants, beginning balance | 150,000 | 150,000 | |
| Weighted average exercise price, beginning balance | $ 1.20 | $ 1.20 | |
| Weighted average remaining contractual life (year) | 1 year 2 months 12 days | 1 year 8 months 12 days | 2 years 8 months 12 days |
| Number of warrants, granted | |||
| Number of warrants, exercised | |||
| Number of warrants, expired or forfeited | |||
| Number of warrants, beginning balance | 150,000 | 150,000 | 150,000 |
| Weighted average exercise price, beginning balance | $ 1.20 | $ 1.20 | $ 1.20 |
| Number of warrants, exercisable | 150,000 | ||
| Weighted average exercise price, exercisable | $ 1.20 | ||
| Weighted average remaining contractual life (year), exercisable | 1 year 2 months 12 days | ||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non option weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non option weighted average grant date fair value exercisable. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by sharebased payment award non options exercisable weighted average remaining contractual term 2. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by sharebased payment award non options outstanding weighted average remaining contractual term 2. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|